MEK inhibition prevents CAR-T cell exhaustion and differentiation via downregulation of c-Fos and JunB
{{output}}
Clinical evidence supports the notion that T cell exhaustion and terminal differentiation pose challenges to the persistence and effectiveness of chimeric antigen receptor-T (CAR-T) cells. MEK1/2 inhibitors (MEKIs), widely used in cancer treatment due to their... ...
